SCHEMBL8070028

SCHEMBL8070028

CCC(NC=O)NC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27858299 0.97 ADH1B (0.43)
SCHEMBL5237219 0.86
SCHEMBL8068066 0.77 ADH1B (0.46)
SCHEMBL269618 0.75
SCHEMBL11423071 0.73 ADH1B (0.42)
SCHEMBL13074302 0.73
SCHEMBL25180 0.73
SCHEMBL14399676 0.73 ADH1B (0.54)
SCHEMBL21336465 0.72
SCHEMBL7753100 0.71 ADH1B (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106083714-B N- (4- { [bis- (methyl oxygroup) quinolyl-4s of 6,7-] oxygroup } phenyl)-N '-(4- fluorophenyl) cyclopropane -1,1- diformamide malate and its crystal type 埃克塞里艾克西斯公司 2019-11-26 CN claimed
CN-105153028-B Compound as c-Met kinase inhibitor 南京爱德程医药科技有限公司 2019-03-26 CN claimed
CN-103748074-B Aryloxy group quinoline derivatives and therapeutical uses thereof TIANJIN LONGBOGEN PHARMACEUTICAL Co.,Ltd. (CN) 2016-05-18 CN claimed
CN-110511158-A The method for preparing quinoline EXELIXIS INC 2019-11-29 CN disclosed
CN-106083714-B N- (4- { [bis- (methyl oxygroup) quinolyl-4s of 6,7-] oxygroup } phenyl)-N '-(4- fluorophenyl) cyclopropane -1,1- diformamide malate and its crystal type 埃克塞里艾克西斯公司 2019-11-26 CN disclosed
CN-110352057-A Combination of cabozantinib and astuzumab for treatment of cancer 埃克塞里艾克西斯公司 2019-10-18 CN disclosed
CN-104370811-B A kind of novel crystal forms of quinoline compound and preparation method thereof 广东东阳光药业有限公司 2019-02-12 CN disclosed
CN-109069499-A Use N- (4- (6,7- dimethoxy-quinoline -4- base oxygroup) phenyl)-N '-(4- fluorophenyl) cyclopropane -1,1- diformamide, the method for (2S)-hydroxysuccinic acid salts for treating clear-cell carcinoma 埃克塞里艾克西斯公司 2018-12-21 CN disclosed
CN-108929324-A The preparation and application of novel 1,1- cyclopropyl diamide derivatives 南开大学 2018-12-04 CN disclosed
CN-108530464-A A kind of multiple target point kinase inhibitor 深圳海王医药科技研究院有限公司 2018-09-14 CN disclosed
CN-108472242-A Pharmaceutical composition for treating cancer 埃克塞里艾克西斯公司 2018-08-31 CN disclosed
CN-101932586-A Inhibition of protein tyrosine kinase activity METHYLGENE INC 2010-12-29 CN disclosed
CN-101796055-A Inhibitors of VEGF receptor and HGF receptor signaling METHYLGENE INC 2010-08-04 CN disclosed
EP-1018536-A1 LUMINESCENT PLASTIC MATERIAL AND PROCESS FOR PRODUCING THE SAME KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2000-07-12 EP disclosed
EP-0927745-A1 OPTICAL PLASTIC MATERIAL AND PROCESS FOR THE PRODUCTION THEREOF KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1999-07-07 EP disclosed
EP-0036129-B1 PROCESS FOR THE PREPARATION OF IMIDAZOLES BASF Aktiengesellschaft (DE) 1984-06-13 EP disclosed
EP-0025191-B1 PROCESS FOR THE PREPARATION OF IMIDAZOLES BASF Aktiengesellschaft (DE) 1983-05-25 EP disclosed
US-4340744-A METAL OXIDES AS CATALYSTS BASF AKTIENGESELLSCHAFT (DE) 1982-07-20 US disclosed
EP-0036129-A1 Process for the preparation of imidazoles BASF Aktiengesellschaft (DE) 1981-09-23 EP disclosed
EP-0025191-A1 Process for the preparation of imidazoles BASF Aktiengesellschaft (DE) 1981-03-18 EP disclosed